A Randomized, Double-blind, Placebo-controlled Trial to Determine the Effects and Duration of Action of Tiotropium Bromide on Pulmonary Function in Persons With SCI
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Mar 2017
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 28 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 28 Feb 2017 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2017.
- 28 Feb 2017 Status changed from recruiting to active, no longer recruiting.